Page-2 of Topic: Bharat Biotech
India-Bangladesh sign MoU on COVID-19 Vaccine
On November 5, 2020, the Government of Bangladesh signed a Memorandum of Understanding with the Serum Institute of India for priority delivery of 3 crore COVID-19 vaccine doses....
Phase-2 trials of Bharat Biotech vaccine to begin in September
As reported by India Today, the phase I trial for the COVID 19 vaccine made by Bharat Biotech is complete and the Phase II of this trial is... Dr. Dangs Lab to Partner with Bharat Biotech for Human Trials of Covaxin
The Delhi-based private laboratory, Dr Dangs Lab, has announced that they have been selected as the central laboratory for human clinical trials of Covaxin, which is touted as...
India begins human trials of COVID-19 vaccines
On July 13, 2020, the AIIMS (All India Institute of Medical Sciences) Patna began human trials of COVID-19 on 10 volunteers. Highlights The first dose was given to...
ICMR to launch COVAXIN on August 15
On July 2, 2020, Indian Council of Medical Research announced that it is to launch COVAXIN, India’s first COVID-19 vaccine by August 15. Highlights There are 12 institutes...
Bharat Biotech’s Typbar-TCV: WHO approves Indian typhoid vaccine for global use
The World Health Organisation (WHO) has given its pre-qualification to Typbar Typhoid Conjugate Vaccine (TVC) developed by Hyderabad based Bharat Biotech for global use. Typbar TCV is world’s...
